DIA-Based Peptide Quantification Service

MtoZ Biolabs provides DIA-based peptide quantification services using data-independent acquisition (DIA) mass spectrometry for comprehensive peptide identification and quantitative comparison.

The service enables measurement of peptide abundance changes across biological samples by integrating DIA-MS acquisition, peptide-level data processing, and quantitative bioinformatics analysis. It supports projects requiring reproducible peptide profiling, comparative analysis, and large-scale peptide measurement.

What Is DIA-Based Peptide Quantification?

DIA-based peptide quantification is a mass spectrometry-based approach designed to measure the relative abundance of peptide species across biological samples. During DIA-MS acquisition, peptide precursor ions within predefined isolation windows are systematically fragmented to generate comprehensive peptide fragmentation data. These data are computationally processed to identify peptides and extract quantitative information from peptide signals.

Depending on the research objective, analyzed peptides may include endogenous peptides or peptides generated from protein-derived samples. DIA-based peptide quantification provides a consistent strategy for comparing peptide abundance patterns across multiple biological conditions.

Technical Principles

DIA-based peptide quantification relies on systematic LC-MS/MS acquisition and computational extraction of peptide-specific quantitative information. Unlike DDA, which selects precursor ions based on intensity during each acquisition cycle, DIA collects fragmentation information across defined mass windows. This acquisition strategy improves measurement consistency and reduces missing quantitative values across multiple samples.

The resulting data are used for relative peptide abundance comparison. For projects requiring absolute peptide concentration measurement, targeted quantitative approaches with stable isotope-labeled standards are generally applied.

Goetze, S. et al. Clinical Proteomics, 2024.

Figure1. Diagram of DIA Acquisition Mode

Choose the Right Workflow 

Different acquisition strategies are suitable for different peptide analysis objectives.

	DIA-Based Peptide Quantification	DDA-Based Peptide Analysis
Acquisition strategy	Systematic acquisition across predefined isolation windows	Precursor selection based on signal intensity
Quantitative consistency	High consistency across multiple samples	More susceptible to missing measurements
Suitable projects	Comparative peptide quantification and large-scale peptide profiling	Discovery-oriented peptide identification

DIA-based peptide quantification is particularly suitable for projects requiring reproducible peptide abundance measurement across multiple biological samples or experimental groups.

DIA-Based Peptide Quantification Service at MtoZ Biolabs

MtoZ Biolabs provides integrated DIA-based peptide quantification services covering peptide preparation, DIA-MS acquisition, quantitative analysis, and biological interpretation.

1. Peptide Preparation

Peptide samples are prepared according to sample origin, peptide characteristics, and study requirements. For protein-derived peptide analysis, enzymatic digestion strategies can be incorporated when required.

2. DIA-MS Acquisition

Prepared peptide samples are analyzed using DIA-based LC-MS/MS acquisition strategies to generate comprehensive peptide fragmentation information.

3. Peptide Identification and Quantification

DIA datasets are processed to identify peptide signals and extract quantitative information for peptide abundance comparison across samples.

4. Bioinformatics Analysis

Quantitative peptide results are evaluated through statistical comparison and functional interpretation according to project objectives.

The workflow is customized according to peptide characteristics, sample type, experimental design, and quantitative objectives. By combining standardized LC-MS/MS workflows with DIA data processing strategies, MtoZ Biolabs supports reliable peptide-level quantitative analysis for complex biological studies.

Sample Submission Requirements

MtoZ Biolabs supports DIA-based peptide quantification for various biological samples, including tissues, cells, biological fluids, microbial samples, and prepared peptide samples. Sample requirements depend on peptide origin, sample type, abundance, and study objectives. Specific requirements for sample amount, preparation method, and shipping conditions can be evaluated according to project characteristics.

For detailed sample submission guidelines, please contact MtoZ Biolabs for project-specific recommendations.

Deliverables

Typical deliverables include:

• Peptide identification and quantitative abundance results
• Peptide abundance comparison across samples
• Differential peptide analysis between experimental groups
• Peptide-level functional annotation and pathway analysis
• Final analysis report

Applications

DIA-based peptide quantification supports research projects requiring reliable peptide-level quantitative information, including:

1. Peptide Profiling Studies

Characterize peptide abundance patterns across different biological conditions.

2. Biomarker Research

Evaluate candidate peptide markers through comparative quantitative analysis.

3. Disease-Related Peptide Analysis

Investigate peptide alterations associated with disease models or biological states.

4. Mechanistic Studies

Analyze peptide changes involved in biological regulation and molecular processes.

5. Multi-Omics Integration

Combine peptide quantitative data with other omics datasets for broader biological interpretation.

Why Choose MtoZ Biolabs?

1. Customized Workflow Development

DIA-based peptide quantification workflows are customized according to peptide characteristics, sample types, and study objectives to support different research requirements.

2. DIA-MS Technical Expertise

Experienced DIA-MS workflows and optimized acquisition strategies are applied to generate consistent peptide-level quantitative data across complex sample sets.

3. Complex Sample Analysis Experience

MtoZ Biolabs supports peptide quantification projects involving diverse biological samples, including tissues, cells, biological fluids, microbial samples, and prepared peptide samples.

4. Comprehensive Data Interpretation

Dedicated bioinformatics pipelines support peptide identification, quantitative comparison, and biological interpretation to help researchers extract meaningful insights from DIA datasets.

5. End-to-End Project Support

MtoZ Biolabs provides support throughout project planning, sample evaluation, experimental execution, and data analysis to facilitate efficient project implementation.

FAQ

Q1. What are the advantages of DIA-based peptide quantification?

DIA-based peptide quantification provides systematic peptide measurement with improved quantitative consistency and reduced missing values, making it suitable for multi-sample comparative studies.

Q2. Can DIA-based peptide quantification analyze endogenous peptides?

Yes. DIA-based peptide quantification can be applied to endogenous peptide analysis as well as protein-derived peptide analysis, depending on sample type and research objectives.

Q3. Can DIA-based peptide quantification provide absolute peptide concentrations?

DIA-based peptide quantification primarily provides relative peptide abundance comparison between samples. Absolute peptide concentration measurement generally requires targeted quantitative workflows using stable isotope-labeled standards.

Start Your Project with MtoZ Biolabs

MtoZ Biolabs provides customized DIA-based peptide quantification solutions for researchers requiring reproducible peptide-level quantitative analysis.

Whether your project focuses on endogenous peptide profiling, protein-derived peptide analysis, or comparative peptide abundance measurement, our team can help develop an appropriate DIA-MS workflow based on sample characteristics and research objectives.

Contact MtoZ Biolabs to discuss your peptide quantification project requirements.